Skip to main content
Erschienen in: Rheumatology International 7/2017

29.05.2017 | Public Health

Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study

verfasst von: María Pilar Cruz-Domínguez, Grettel García-Collinot, Miguel Angel Saavedra, Daniel H. Montes-Cortes, Rubén Morales-Aguilar, Rosa Angélica Carranza-Muleiro, Olga L. Vera-Lastra, Luis J. Jara

Erschienen in: Rheumatology International | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Factors for mortality in systemic sclerosis (SSc) vary in different cohorts around the world. Case–control study nested in a cohort. We included patients ≥16 years of age with SSc (ACR/EULAR 2013), from 2005 to 2015. Demographic and clinical variables and causes of mortality were recorded. We calculated Crude Mortality Rate (CMR), Standardized Mortality Ratio (SMR), and Kaplan–Meier survival analysis was performed. A Cox proportional hazard (HR) regression analysis of the potential risk factors associated with mortality was also performed. A total of 220 patients with SSc were included. During follow-up, 28 deaths occurred. The sum of total time contributed by all subjects was 1074 years-person, the CMR was 12.72%, the overall SMR was 4.5, in women 3.7, and in men 4.7. The survival rate at 5 and 10 years was 83 and 70%, respectively. The causes of death were definitively attributed to SSc in 21.4% of the cases, probably in 28.7%, unrelated in 35.6%, and unknown in 14.3%. The direct cause of death of the patients was infection in 25% of cases, cardiovascular disease in 14%, lung involvement in 14%, pulmonary embolism in 11%, and neoplasia in 11%. The Cox regression analysis showed that the factors associated with mortality were: male gender (HR 5.84, CI 95% 1.31–26, p = 0.013), severe Medsger’s score for general symptoms (HR 5.12, CI 95% 1.74–14.97, p = 0.021) and severe malnutrition (HR 3.77, CI 95% 1.23–11.06, p = 0.008). Infections, cardiovascular disease, and lung involvement were the leading cause of death. Male gender and severe general affection and malnutrition were associated with a poorer prognosis of SSc.
Literatur
1.
Zurück zum Zitat Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219CrossRefPubMed Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219CrossRefPubMed
2.
Zurück zum Zitat Cruz-Domínguez MP, Montes-Cortes DH, Olivares-Corichi IM, Vera-Lastra O, Medina G, Jara LJ (2013) Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis. Rheumatol Int 33(9):2261–2267CrossRefPubMed Cruz-Domínguez MP, Montes-Cortes DH, Olivares-Corichi IM, Vera-Lastra O, Medina G, Jara LJ (2013) Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis. Rheumatol Int 33(9):2261–2267CrossRefPubMed
3.
Zurück zum Zitat Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
4.
Zurück zum Zitat Medsgers TA Jr, Silman AJ, Steen VD, Black CM, Akesson A et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheum 26(10):2159–2167 Medsgers TA Jr, Silman AJ, Steen VD, Black CM, Akesson A et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheum 26(10):2159–2167
5.
Zurück zum Zitat Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M et al (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94(43):e1728CrossRef Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Campillo-Grau M, Ramos-Casals M et al (2015) Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death. Medicine (Baltimore) 94(43):e1728CrossRef
6.
Zurück zum Zitat Rojas-Serrano J, Codina-Velásquez H, Medrano-Ramírez G, Abraham Simón J, Vera-Lastra O, Vázquez-Mellado J (2008) Lower incidence of severe damage to target organs in mexican patients with systemic sclerosis and diffuse skin affection. Reumatol Clin 4(1):3–7CrossRefPubMed Rojas-Serrano J, Codina-Velásquez H, Medrano-Ramírez G, Abraham Simón J, Vera-Lastra O, Vázquez-Mellado J (2008) Lower incidence of severe damage to target organs in mexican patients with systemic sclerosis and diffuse skin affection. Reumatol Clin 4(1):3–7CrossRefPubMed
7.
Zurück zum Zitat Van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral Van den Hoogen F, Khanna D, Fransen J et al (2013) 2013 Classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Chang R (1984) Nutritional assessment using a microcomputer 2. Programme evaluation. Clin Nutr 3:75–82CrossRefPubMed Chang R (1984) Nutritional assessment using a microcomputer 2. Programme evaluation. Clin Nutr 3:75–82CrossRefPubMed
10.
Zurück zum Zitat Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:154–167CrossRef Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR et al (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 81:154–167CrossRef
11.
Zurück zum Zitat Simeon CP, Armandans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42:71–75CrossRefPubMed Simeon CP, Armandans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology 42:71–75CrossRefPubMed
12.
Zurück zum Zitat Geirson AJ, Steisson K, Gudmundsson S, Sigurdsson V (1994) Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 53:502–505CrossRef Geirson AJ, Steisson K, Gudmundsson S, Sigurdsson V (1994) Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 53:502–505CrossRef
13.
Zurück zum Zitat Ferri C, Valentini G, Cozzi F et al (2002) Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81:139–153CrossRef Ferri C, Valentini G, Cozzi F et al (2002) Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1012 Italian patients. Medicine (Baltimore) 81:139–153CrossRef
14.
Zurück zum Zitat Ferri C, Sebastiani M, Lo Monaco A, Iudici M, Giuggioli D, Furini F (2014) Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev 13(10):1026–1034CrossRefPubMed Ferri C, Sebastiani M, Lo Monaco A, Iudici M, Giuggioli D, Furini F (2014) Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev 13(10):1026–1034CrossRefPubMed
15.
Zurück zum Zitat Tomiyama F, Watanabe R, Ishii T, Kamogawa Y, Fujita Y, Shirota Y (2016) High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis. Tohoku J Exp Med 239(4):297–305CrossRefPubMed Tomiyama F, Watanabe R, Ishii T, Kamogawa Y, Fujita Y, Shirota Y (2016) High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis. Tohoku J Exp Med 239(4):297–305CrossRefPubMed
16.
Zurück zum Zitat Bhansing KJ, van Riel PL, van Engelen BG, Fransen J, Vonk MC (2016) Patients with Systemic sclerosis/polymyositis overlap have a worse survival rate than patients without it. J Rheumatol 43(10):1838–1843CrossRefPubMed Bhansing KJ, van Riel PL, van Engelen BG, Fransen J, Vonk MC (2016) Patients with Systemic sclerosis/polymyositis overlap have a worse survival rate than patients without it. J Rheumatol 43(10):1838–1843CrossRefPubMed
17.
Zurück zum Zitat Stricklan G, Pauling J, Cavill C, Shaddick G, McHugh N (2013) Mortality in systemic sclerosis-a single centre study from the UK. Clin Rheumatol 32:1533–1539CrossRef Stricklan G, Pauling J, Cavill C, Shaddick G, McHugh N (2013) Mortality in systemic sclerosis-a single centre study from the UK. Clin Rheumatol 32:1533–1539CrossRef
18.
Zurück zum Zitat Abu-Shakra M, Lee P (1995) Mortality in systemic sclerosis: a comparison to the general population. J Rheumatol 22:2100–2102PubMed Abu-Shakra M, Lee P (1995) Mortality in systemic sclerosis: a comparison to the general population. J Rheumatol 22:2100–2102PubMed
19.
Zurück zum Zitat Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology 51:1017–1026CrossRefPubMed Elhai M, Meune C, Avouac J, Kahan A, Allanore Y (2012) Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. Rheumatology 51:1017–1026CrossRefPubMed
20.
Zurück zum Zitat Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26(5):663–670CrossRefPubMed Falagas ME, Manta KG, Betsi GI, Pappas G (2007) Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 26(5):663–670CrossRefPubMed
21.
Zurück zum Zitat Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755CrossRefPubMed Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755CrossRefPubMed
22.
Zurück zum Zitat Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815CrossRefPubMed Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815CrossRefPubMed
23.
Zurück zum Zitat Schiopu E, Au KM, McMahon MA, Kaplan MJ, Divekar A, Singh RR, Furst DE, Clements PJ, Ragvendra N, Zhao W, Maranian P, Khanna D (2014) Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) 53(4):704–713CrossRef Schiopu E, Au KM, McMahon MA, Kaplan MJ, Divekar A, Singh RR, Furst DE, Clements PJ, Ragvendra N, Zhao W, Maranian P, Khanna D (2014) Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) 53(4):704–713CrossRef
25.
Zurück zum Zitat Lee P, Langevitz P, Alderdice CA et al (1992) Mortality in systemic sclerosis (scleroderma). Quart J Med 82(298):139–148PubMed Lee P, Langevitz P, Alderdice CA et al (1992) Mortality in systemic sclerosis (scleroderma). Quart J Med 82(298):139–148PubMed
26.
Zurück zum Zitat Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39(10):1971–1978CrossRefPubMed Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM (2012) Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients. J Rheumatol 39(10):1971–1978CrossRefPubMed
27.
Zurück zum Zitat Wielosz E, Majdan M, Dryglewska M, Suszek D (2015) Comparison of clinical and serological parameters in female and male patients with systemic sclerosis. Reumatologia 53(6):315–320CrossRefPubMed Wielosz E, Majdan M, Dryglewska M, Suszek D (2015) Comparison of clinical and serological parameters in female and male patients with systemic sclerosis. Reumatologia 53(6):315–320CrossRefPubMed
28.
Zurück zum Zitat Kaysen AG, Dubin JA, Müller HG, Rosales L, Levin NW, Mitch WE, The Hemo Study Group (2004) Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 65:1408–1415CrossRefPubMed Kaysen AG, Dubin JA, Müller HG, Rosales L, Levin NW, Mitch WE, The Hemo Study Group (2004) Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 65:1408–1415CrossRefPubMed
29.
Zurück zum Zitat Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanoune I (2016) Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep. doi:10.1093/gastro/gow013 Bharadwaj S, Ginoya S, Tandon P, Gohel TD, Guirguis J, Vallabh H, Jevenn A, Hanoune I (2016) Malnutrition: laboratory markers vs nutritional assessment. Gastroenterol Rep. doi:10.​1093/​gastro/​gow013
30.
Zurück zum Zitat Codullo V, Cereda E, Klersy C, Cavazzana I, Alpini C, Bonardi C (2016) Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients. Rheumatology (Oxford) 55(2):315–319CrossRef Codullo V, Cereda E, Klersy C, Cavazzana I, Alpini C, Bonardi C (2016) Serum prealbumin is an independent predictor of mortality in systemic sclerosis outpatients. Rheumatology (Oxford) 55(2):315–319CrossRef
Metadaten
Titel
Malnutrition is an independent risk factor for mortality in Mexican patients with systemic sclerosis: a cohort study
verfasst von
María Pilar Cruz-Domínguez
Grettel García-Collinot
Miguel Angel Saavedra
Daniel H. Montes-Cortes
Rubén Morales-Aguilar
Rosa Angélica Carranza-Muleiro
Olga L. Vera-Lastra
Luis J. Jara
Publikationsdatum
29.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 7/2017
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3753-y

Weitere Artikel der Ausgabe 7/2017

Rheumatology International 7/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.